Alpine Woods Capital Investors, LLC Verastem, Inc. Transaction History

Alpine Woods Capital Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$0.86 - $1.44 $43,000 - $72,000	-50,000 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$1.21 - $1.59 $48 - $63	-40 Reduced 0.08%	50,000 $61,000
Q4 2018 Feb 13, 2019	SELL	$3.23 - $7.01 $16,150 - $35,050	-5,000 Reduced 9.08%	50,040 $168,000
Q2 2018 Aug 09, 2018	BUY	$2.88 - $8.67 $14,400 - $43,350	5,000 Added 9.99%	55,040 $379,000
Q3 2017 Nov 08, 2017	BUY	$3.01 - $5.41 $150,620 - $270,716	50,040	50,040 $235,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $840M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.